Similar to the ABCA1 pathway, problems with CPLA2 also lead to oxidation that later triggers inflammation in the brain. Inhibiting CPLA2 might offer another way to prevent or treat Alzheimer's ...

The study, the culmination of a decade of research on a protein known as ATP-binding cassette transporter A1 (ABCA1), was just published in the journal Molecular Neurodegeneration. Past research ...

Potential biomarkers for adjuvant therapy patient selection. Oncological outcomes according to ABCA1/G1 staining intensity expression.